Syncona Limited (SYNC)

Category Alternative Other

This investment trust can be held in an Investment ISA, SIPP and Investment Account

Sell

111.00p

Buy

111.40p

arrow-down-0.40p (-0.36%)

Discount/Premium

-41.23%

Estimated NAV

188.20p

Prices updated at 31 May 2024, 16:39 BST

Prices minimum 15 mins delay

Prices in GBX

Investment objective

To achieve superior long-term capital appreciation from its investments. The Company invests in life science businesses and single or multi-asset projects. The Company will target an IRR per share across its investment portfolio of 15% p.a. over the long term. Over time, it is intended that the Company should invest the significant majority of its assets in Life Science Investments.

FTSE All-Share

0.5%

LSE

Important documents: Please ensure that you have read the Key Information Document/Technical Guide , Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

	111.00
Launch date	26 Oct 2012
	111.80p - 110.31p
	160.80p - 105.00p
	188.20 as of 31 Dec 2023
Ongoing charge audited (%)	0.88
	0.93
	0.01
	0.00
	816,993.14
	649.35m
	718.18m
	99.35
	Annually
	£1,222.08m
	£1,222.08m
	-35.30
	-30.52
	-12.09
Fund comparative index	FTSE 250 TR GBP
	Quarterly
	0.76m
	0.96m
	GG00B8P59C08

Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.